Ophthalmology 360 (@oph360) 's Twitter Profile
Ophthalmology 360

@oph360

Ophthalmology 360. Digital Media Brand helping the Patients to see better; better outcomes #ophthalmology

ID: 1128669569344835584

linkhttp://www.ophthalmology360.com/ calendar_today15-05-2019 14:32:49

1,1K Tweet

736 Followers

632 Following

Ophthalmology 360 (@oph360) 's Twitter Profile Photo

June is Cataract Awareness Month! 👁️ 👁️ Did you know cataracts are a leading cause of vision loss but are treatable? Regular eye check-ups can help catch them early and keep your world clear and bright. Don’t wait—protect your sight! 💙 #Cataracts #CataractAwareness #EyeHealth

June is Cataract Awareness Month! 👁️ 👁️

Did you know cataracts are a leading cause of vision loss but are treatable? Regular eye check-ups can help catch them early and keep your world clear and bright. Don’t wait—protect your sight! 💙

#Cataracts #CataractAwareness #EyeHealth
Ophthalmology 360 (@oph360) 's Twitter Profile Photo

Early surgery for congenital cataracts significantly lowers the risk of amblyopia in children, but it also increases the risk of complications like glaucoma, according to a study. Read more ⤵️ ophthalmology360.com/early-onset-ca… #EarlyOnSetCataracts #Cataracts #Amblyopia #Pediatrics

Ophthalmology 360 (@oph360) 's Twitter Profile Photo

The newly debuted OMNI® Edge Surgical System is indicated for canaloplasty followed by trabeculotomy to reduce intraocular pressure in adults with primary open-angle glaucoma. Read More: ophthalmology360.com/spotlight-seri… #IntraocularPressure #IOP #OpenAngleGlaucoma #Glaucoma #EyeSurgery

The newly debuted OMNI® Edge Surgical System is indicated for canaloplasty followed by trabeculotomy to reduce intraocular pressure in adults with primary open-angle glaucoma.

Read More:
ophthalmology360.com/spotlight-seri…

#IntraocularPressure #IOP #OpenAngleGlaucoma #Glaucoma #EyeSurgery
Ophthalmology 360 (@oph360) 's Twitter Profile Photo

"Clinical research sites are facing a mounting operational crisis. While the number of trials continues to grow and protocols become more complex, the systems and staffing models supporting site operations have remained largely static." Read more. ophthalmology360.com/trending-topic… #AI

"Clinical research sites are facing a mounting operational crisis. While the number of trials continues to grow and protocols become more complex, the systems and staffing models supporting site operations have remained largely static."

Read more.
ophthalmology360.com/trending-topic…

#AI
Ophthalmology 360 (@oph360) 's Twitter Profile Photo

A recent narrative review examining 92 studies from 2019 to 2024 found that firework-related eye injuries remain a significant contributor to ophthalmic trauma (OT) in children. Read more below: ophthalmology360.com/pediatrics/fir… #Ophthalmology360 #Fireworks #EyeInjury #OphthalmicTrauma

A recent narrative review examining 92 studies from 2019 to 2024 found that firework-related eye injuries remain a significant contributor to ophthalmic trauma (OT) in children.

Read more below:
ophthalmology360.com/pediatrics/fir…

#Ophthalmology360 #Fireworks #EyeInjury #OphthalmicTrauma
Ophthalmology 360 (@oph360) 's Twitter Profile Photo

The Tender study is a prospective, open-label, single-center, randomized, investigator-initiated clinical study that seeks to investigate the safety and efficacy of a 0.4-mg dexamethasone sustained-release intracanalicular insert. Read more: ophthalmology360.com/pediatrics/the… #Pediatrics

The Tender study is a prospective, open-label, single-center, randomized, investigator-initiated clinical study that seeks to investigate the safety and efficacy of a 0.4-mg dexamethasone sustained-release intracanalicular insert.

Read more:
ophthalmology360.com/pediatrics/the…

#Pediatrics
Ophthalmology 360 (@oph360) 's Twitter Profile Photo

🧠 Did you know? Over 16 million Americans suffer from #DryEyeDisease. This #DryEyeAwarenessMonth, learn the signs and seek relief. Learn more from Mitchell Jackson, MD, with the link below. ophthalmology360.com/dry-eye/costs-… #Ophthalmology360 #DryEyeAwareness #EyeHealth #DryEye

🧠 Did you know? Over 16 million Americans suffer from #DryEyeDisease. This #DryEyeAwarenessMonth, learn the signs and seek relief. 

Learn more from Mitchell Jackson, MD, with the link below.
ophthalmology360.com/dry-eye/costs-…

#Ophthalmology360 #DryEyeAwareness #EyeHealth #DryEye
Ophthalmology 360 (@oph360) 's Twitter Profile Photo

#July is #UVSafetyAwarenessMonth — a timely reminder of the importance of protecting your skin and eyes from harmful ultraviolet (UV) radiation. 🧴Use broad-spectrum sunscreen 👕 Wear protective clothing ☀️ Avoid peak sun exposure #UVSafety #SkinHealth #PublicHealthAwareness

#July is #UVSafetyAwarenessMonth — a timely reminder of the importance of protecting your skin and eyes from harmful ultraviolet (UV) radiation. 

🧴Use broad-spectrum sunscreen
👕 Wear protective clothing
☀️ Avoid peak sun exposure 

#UVSafety #SkinHealth #PublicHealthAwareness
Ophthalmology 360 (@oph360) 's Twitter Profile Photo

Despite advances in surgery and early detection, the number of people affected by cataracts has steadily increased from 1990 to 2021 and is expected to continue rising through 2030. Read more ⬇️ ophthalmology360.com/early-onset-ca… #EarlyOnsetCataracts #Cataracts #Cataract #DiseaseBurden

Ophthalmology 360 (@oph360) 's Twitter Profile Photo

For infants with unilateral cataracts, cataract surgery performed before 2 months of age leads to better visual outcomes at 5 years compared to later surgery, according to a study. Read more: ophthalmology360.com/early-onset-ca… #PediatricOphthlmology #Pediatrics #Cataracts #Catarct #Vision

Ophthalmology 360 (@oph360) 's Twitter Profile Photo

July is #DryEyeAwarenessMonth, and this month's Spotlight Series article features MIEBO (perfluorohexyloctane #Ophthalmic solution), the first and only FDA-approved treatment for the symptoms of #DryEyeDisease that directly targets #TearEvaporation. 🔗: ophthalmology360.com/spotlight-seri…

July is #DryEyeAwarenessMonth, and this month's Spotlight Series article features MIEBO (perfluorohexyloctane #Ophthalmic solution), the first and only FDA-approved treatment for the symptoms of #DryEyeDisease that directly targets #TearEvaporation.

🔗: ophthalmology360.com/spotlight-seri…
Ophthalmology 360 (@oph360) 's Twitter Profile Photo

Join a dynamic community of women leaders in #ophthalmology at the 2025 WIO Summer Symposium, August 7–10 at The Ritz-Carlton, Amelia Island. 🏝️ Learn more w/ the link below: wioonline.org/summer-symposi… #Florida #Ophthalmology #WomenInOphthalmology #WomenInMedicine WIO

Join a dynamic community of women leaders in #ophthalmology at the 2025 WIO Summer Symposium, August 7–10 at The Ritz-Carlton, Amelia Island. 🏝️

Learn more w/ the link below:
wioonline.org/summer-symposi…

#Florida #Ophthalmology #WomenInOphthalmology #WomenInMedicine <a href="/WIO_WomenInOpht/">WIO</a>
Ophthalmology 360 (@oph360) 's Twitter Profile Photo

Join a dynamic community of women leaders in #ophthalmology at the 2025 WIO Summer Symposium, August 7–10 at The Ritz-Carlton, Amelia Island. Learn more w/ the link below: wioonline.org/summer-symposi… #Florida #Ophthalmology #WomenInOphthalmology #WomenInMedicine WIO

Join a dynamic community of women leaders in #ophthalmology at the 2025 WIO Summer Symposium, August 7–10 at The Ritz-Carlton, Amelia Island. 

Learn more w/ the link below:
wioonline.org/summer-symposi…

#Florida #Ophthalmology #WomenInOphthalmology #WomenInMedicine 
<a href="/WIO_WomenInOpht/">WIO</a>
Ophthalmology 360 (@oph360) 's Twitter Profile Photo

Honoring the dedication and expertise of #ophthalmologists worldwide who work tirelessly to preserve and restore #vision. Your commitment to #eyehealth makes a lasting impact every day. Happy World Ophthalmologist Day! #Ophthalmology360 #WorldOphthalmologistDay

Honoring the dedication and expertise of #ophthalmologists worldwide who work tirelessly to preserve and restore #vision. Your commitment to #eyehealth makes a lasting impact every day. Happy World Ophthalmologist Day!

#Ophthalmology360 #WorldOphthalmologistDay
Ophthalmology 360 (@oph360) 's Twitter Profile Photo

👁️ August is Children’s Eye Health and Safety Awareness Month! A perfect time to prioritize your child’s #vision with regular #eyeexams and safe habits. Protect their sight today for a brighter tomorrow. ☀️ #PediatricOphthalmology

👁️ August is Children’s Eye Health and Safety Awareness Month! A perfect time to prioritize your child’s #vision with regular #eyeexams and safe habits. 

Protect their sight today for a brighter tomorrow. ☀️

#PediatricOphthalmology
Ophthalmology 360 (@oph360) 's Twitter Profile Photo

“The Patient Voice is so Important” For #NationalPatientAdvocacyDay, there is no one who advocates more for others than Hillary Golden (Hillary A Golden 🚢), founder of Glaucoma Coach. Hillary's interview is out on the MyHero360 YT channel. 🔗: youtube.com/watch?v=2ROHnS… #Advocacy

“The Patient Voice is so Important”

For #NationalPatientAdvocacyDay, there is no one who advocates more for others than Hillary Golden (<a href="/HillaryA_Golden/">Hillary A Golden 🚢</a>), founder of Glaucoma Coach.

Hillary's interview is out on the <a href="/myhero360/">MyHero360</a> YT channel.

🔗: youtube.com/watch?v=2ROHnS…

#Advocacy
Ophthalmology 360 (@oph360) 's Twitter Profile Photo

This month's Spotlight Series article features a look at #Oxervate® (cenegermin-bkbj), the first and only FDA-approved treatment option for patients with #NeurotrophicKeratitis. Learn more about the efficacy and safety of Oxervate®: ophthalmology360.com/neurotrophic-k… #Ophthalmology360

This month's Spotlight Series article features a look at #Oxervate® (cenegermin-bkbj), the first and only FDA-approved treatment option for patients with #NeurotrophicKeratitis.

Learn more about the efficacy and safety of Oxervate®:
ophthalmology360.com/neurotrophic-k…

#Ophthalmology360
Ophthalmology 360 (@oph360) 's Twitter Profile Photo

In the latest episode of The Ophthalmic Project, Mark Dlugoss speaks with Edward Holland, MD, and Stephen Lane, MD, discuss the goals of The Holland Foundation for Sight Restoration. Watch the discussion: ophthalmology360.com/ocular-surface… #TheHollandFoundation #EyeSurgery #EyeSurgeon

In the latest episode of The Ophthalmic Project, Mark Dlugoss speaks with Edward Holland, MD, and Stephen Lane, MD, discuss the goals of The Holland Foundation for Sight Restoration.

Watch the discussion:
ophthalmology360.com/ocular-surface…

#TheHollandFoundation #EyeSurgery #EyeSurgeon
Ophthalmology 360 (@oph360) 's Twitter Profile Photo

Half-fluence photodynamic therapy combined with a single aflibercept injection effectively improves vision in pachychoroid neovasculopathy; however, approximately 1/3 of patients still experience recurrent fluid. Read more: ophthalmology360.com/retina/combina… #Retina #Vision #Injection

Ophthalmology 360 (@oph360) 's Twitter Profile Photo

The phase 3 PULSAR trial (NCT04423718) has reported 96-week results comparing aflibercept 8 mg at extended dosing intervals with standard aflibercept 2 mg every 8 weeks in treatment-naive patients with nAMD. Read more: ophthalmology360.com/retina/afliber… #AMD #Retina #MacularDegeneration